Loading company…
Riskpilot
← Back to search
Sign in
Get full access
INNOVA MED A/S
A/S
In liquidation
CVR 14867341
Solvænget 23
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 1991
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2020
DKK 27K
-185% vs 2019
EBITDA margin
100.0%
+185% vs 2019
Equity ratio
74.8%
Financial strength
Net profit 2020
DKK 104K
+345% vs 2019
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2016
0M
0%
2017
0M
0%
2018
0M
0%
2019
0M
0%
2020
Key figures
Annual report 2020
Revenue
DKK 27K
-185%
EBITDA
DKK 27K
+185%
Net profit
DKK 104K
+345%
Total assets
DKK 822K
+5%
Equity
DKK 615K
+20%
Employees
—
—
Company information
Legal name
INNOVA MED A/S
CVR number
14867341
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
30. januar 1991
Share capital
DKK 500.000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-06-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Solvænget 23
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Hørsholm
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
0M
2020
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
0M
2020
Income statement
DKK thousands
Item
2016
2017
2018
2019
2020
Revenue
56
-116
8
-32
27
Staff expenses
-0
-0
-0
-0
-0
EBITDA
56
-116
8
-32
27
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
56
-116
8
-32
27
Net financials
18
-18
46
-11
78
Profit before tax
74
-134
54
-43
104
Tax
14
36
79
-0
-0
Net profit
59
-170
-26
-43
104
Balance sheet
DKK thousands
Item
2016
2017
2018
2019
2020
Total assets
1.145
1.072
1.017
782
822
Equity
845
579
554
511
615
Long-term debt
0
0
0
0
0
Short-term debt
300
493
464
271
207
Total debt
300
493
464
271
207
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2016
2020
Equity ratio
74.8%
This company
38.2%
Market median
+96% vs market
2016
2020
Return on equity
16.9%
This company
18.4%
Market median
+8% vs market
2016
2020
Net profit margin
390.0%
This company
8.1%
Market median
+4715% vs market
2016
2020
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
2016
2020
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
2016
2020
Annual reports & filings
Annual report 2020
Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
View
PDF
Annual report 2016
Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Former (3)
TK
Troels Krohn
Board of Directors
2017 – 2020
MK
Mirja Krohn
Board of Directors
2018 – 2020
AG
Allan Georg Becker
Board of Directors
1991 – 2017
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Gerhard Leif Krohn
Individual
100%
100%
1991
Gunnie Jonna Krohn
Individual
100%
100%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of INNOVA MED A/S also hold positions in
0
other companies.
Person
Role here
Other companies
Troels Krohn
Board of Directors
0 companies
Mirja Krohn
Board of Directors
0 companies
Allan Georg Becker
Board of Directors
0 companies